Some visit links earn us a commission.
Quick verdict
Hims & Hers is the better pick for most patients on overall scoring. Same-day prescription, no lock-in and brand-name confidence. Hims pivoted to branded-only in March 2026 after settling with Novo Nordisk; compounded semaglutide is closed to new patients. Headline price is $299/mo branded Wegovy injectable (self-pay), plus $149/mo membership.
That said, Found wins on specific dimensions. Found has the broadest medication catalog of any program here, spanning branded GLP-1s, compounded options and Lilly's newly approved oral pill, Foundayo (orforglipron). The 12-month commitment required for the lowest price is the catch.
Side-by-side
| Hims & Hers | Found | |
|---|---|---|
| Starts from | $299/mo (incl. medication) | $169/mo (incl. medication) |
| Monthly cost gap | Found is $130/mo cheaper than Hims & Hers | |
| Lock-in | Month-to-month | 12-mo lock-in |
| Time to prescription | 1 day | 5 days |
| Consultation type | Asynchronous | Asynchronous |
| Affiliate network | Impact | Impact |
Score by dimension
Scores out of 10, equal-weighted across five dimensions. How we score. The winner of each dimension is highlighted.
| Hims & Hers | Found | |
|---|---|---|
| Pricing transparency | 6/10 | 6/10 |
| Cancellation terms | 9/10 | 3/10 |
| Onboarding experience | 9/10 | 8/10 |
| Medication options | 5/10 | 9/10 |
| Member reviews | 6/10 | 7.8/10 |
When to choose Hims & Hers
Best for fast async onboarding
Patients who want a fast, low-friction async path to a branded GLP-1 prescription with predictable monthly pricing.
Hims & Hers wins on cancellation terms, onboarding experience on the dimensional scoring. The caveat: Patients who wanted Hims's old compounded semaglutide tier or who need insurance-routed branded access. Compounded is closed to new patients. Note also: Settled with Novo Nordisk March 9, 2026 over compounded semaglutide marketing
When to choose Found
Best for complex clinical workups
Patients whose obesity medicine clinician has flagged a non-standard medication path (multiple drug classes, off-label combinations or 503A-compounded options that other programs have exited).
Found wins on medication options, member reviews and runs $130/mo cheaper than Hims & Hers at the entry tier ($169 vs $299). Over a year that's $1,560 you keep. The caveat: Patients new to GLP-1s who want a simple month-to-month commitment. The 12-month plan required for the lowest price is the most punitive structure short of WeightWatchers Clinic. Note also: Subject to ongoing Lilly compounded-tirzepatide enforcement risk
If cost is your main filter
Found is the cheaper monthly: $169 all-in vs $299 for Hims & Hers. That's $130 a month or $1,560a year. The 12-month math matters most if you're planning to maintain on GLP-1 long-term. If you're running a 3-month trial, the $390 delta is small against the cost of stopping early on the wrong dose. Insurance changes the picture: if either program runs prior auth and your plan covers Wegovy or Zepbound, branded with copay can beat both cash-pay totals.
If lock-in is your main filter
Hims & Hers (month-to-month) and Found (12-mo lock-in) sit at different cancellation tiers. If you're first-time on a GLP-1 and unsure how you'll tolerate it, Hims & Hers's easier cancellation is the safer trial.
FAQ
Is Hims & Hers cheaper than Found?
Can I switch from Hims & Hers to Found mid-treatment?
Which program has better member feedback?
Read the full reviews
All head-to-head comparisons → · Full chart → · Cost guide · Programs guide
